ALLR - Allarity Therapeutics GAAP EPS of -$0.72 misses by $0.46 October, 11 2022 04:33 PM Allarity Therapeutics Inc. Allarity Therapeutics press release ( NASDAQ: ALLR ): Q2 GAAP EPS of -$0.72 misses by $0.46 . As of June 30, 2022, Allarity’s cash was $7.7 million, as compared to $19.6 million as of December 31, 2021 Shares +4.07% . For further details see: Allarity Therapeutics GAAP EPS of -$0.72 misses by $0.46